Reuters logo
10 个月前
BRIEF-Acorda Therapeutics presents data from clinical and preclinical trials of CVT-301
2016年10月13日 / 上午11点27分 / 10 个月前

BRIEF-Acorda Therapeutics presents data from clinical and preclinical trials of CVT-301

Oct 13 (Reuters) - Acorda Therapeutics Inc :

* Acorda Therapeutics Inc-presents data from clinical and preclinical trials of CVT-301 for treatment of OFF periods in Parkinson's disease

* Company expects to announce results from its randomized, placebo-controlled Phase 3 trial in Q1 2017 Source text for Eikon: Further company coverage: ;))

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below